These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The MEF2 site is necessary for induction of the myosin light chain 2 slow promoter in overloaded regenerating plantaris muscle. Leszczynski JK; Esser KA Life Sci; 2003 Nov; 73(25):3265-76. PubMed ID: 14561531 [TBL] [Abstract][Full Text] [Related]
27. Characterization of cardiac gene promoter activity: reporter constructs and heterologous promoter studies. Chen HH; Stewart AF Methods Mol Biol; 2007; 366():217-25. PubMed ID: 17568127 [TBL] [Abstract][Full Text] [Related]
28. The cardiac pacemaker-specific channel Hcn4 is a direct transcriptional target of MEF2. Kuratomi S; Ohmori Y; Ito M; Shimazaki K; Muramatsu S; Mizukami H; Uosaki H; Yamashita JK; Arai Y; Kuwahara K; Takano M Cardiovasc Res; 2009 Sep; 83(4):682-7. PubMed ID: 19477969 [TBL] [Abstract][Full Text] [Related]
29. Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Boecker W; Bernecker OY; Wu JC; Zhu X; Sawa T; Grazette L; Rosenzweig A; del Monte F; Schmidt U; Hajjar RJ Mol Imaging; 2004 Apr; 3(2):69-75. PubMed ID: 15296671 [TBL] [Abstract][Full Text] [Related]
31. Targeting transgene to the heart and liver with AAV9 by different promoters. Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818 [TBL] [Abstract][Full Text] [Related]
32. Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters. Franz WM; Rothmann T; Frey N; Katus HA Cardiovasc Res; 1997 Sep; 35(3):560-6. PubMed ID: 9415302 [TBL] [Abstract][Full Text] [Related]
33. Role for early growth response-1 protein in alpha(1)-adrenergic stimulation of fibroblast growth factor-2 promoter activity in cardiac myocytes. Jin Y; Sheikh F; Detillieux KA; Cattini PA Mol Pharmacol; 2000 May; 57(5):984-90. PubMed ID: 10779383 [TBL] [Abstract][Full Text] [Related]
34. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Latham JP; Searle PF; Mautner V; James ND Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585 [TBL] [Abstract][Full Text] [Related]
38. NGF, cyclic AMP, and phorbol esters regulate oxytocin receptor gene transcription in SK-N-SH and MCF7 cells. Bale TL; Dorsa DM Brain Res Mol Brain Res; 1998 Jan; 53(1-2):130-7. PubMed ID: 9473629 [TBL] [Abstract][Full Text] [Related]
39. Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells. Li T; Chen YH; Liu TJ; Jia J; Hampson S; Shan YX; Kibler D; Wang PH Circ Res; 2003 Dec; 93(12):1202-9. PubMed ID: 14593001 [TBL] [Abstract][Full Text] [Related]
40. Method-related effects of adenovirus-mediated LacZ and SERCA1 gene transfer on contractile behavior of cultured failing human cardiomyocytes. Weisser-Thomas J; Dieterich E; Janssen PM; Schmidt-Schweda S; Maier LS; Sumbilla C; Pieske B J Pharmacol Toxicol Methods; 2005; 51(2):91-103. PubMed ID: 15767202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]